Somatus Executive and Leadership Team

Ikenna Okezie, the Co-Founder & Chief Executive Officer at Somatus, directs the overarching strategic vision for the organization. By prioritizing value-based care models, the Co-Founder & Chief Executive Officer architects innovative solutions for patients suffering from Chronic Kidney Disease and End Stage Renal Disease. Okezie manages high-level partnerships with health plans and providers to expand the reach of specialized renal care across North American markets. This leadership role involves constant evaluation of clinical performance metrics to ensure superior patient outcomes. Through rigorous oversight of corporate growth initiatives, Ikenna Okezie drives the mission to reduce hospitalizations and improve quality of life for the patient population. The Co-Founder & Chief Executive Officer maintains alignment between clinical goals and business sustainability, ensuring the company remains a leader in the healthcare management sector while scaling operations to meet increasing demand for specialized renal services.

Rob Ricketts, the Chief Financial Officer at Somatus, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning and analysis, the Chief Financial Officer ensures the company maintains the necessary resources to support specialized care for patients with Chronic Kidney Disease and End Stage Renal Disease. Ricketts directs budgeting processes and financial reporting to provide transparency for stakeholders and investors. This leadership role involves optimizing revenue cycles and managing cost structures to sustain long-term growth across regional operations. By analyzing market trends and healthcare reimbursement models, Rob Ricketts secures the financial stability required for continued innovation in renal care delivery. The Chief Financial Officer collaborates with executive leadership to evaluate investment opportunities that enhance service capabilities. Through disciplined fiscal management, Ricketts supports the broader organizational objective of delivering high-quality, cost-effective healthcare management services to the patient population.

Jason Cline, the Executive Vice President & Transformation Acting Chief Financial Officer at Somatus, leads initiatives focused on organizational evolution and financial process improvement. By identifying opportunities for operational transformation, the Executive Vice President & Transformation Acting Chief Financial Officer drives efficiency gains that support the delivery of care for patients with Chronic Kidney Disease and End Stage Renal Disease. Cline manages the integration of new financial systems and data analytics to enhance decision-making capabilities. This leadership role involves restructuring internal workflows to better align with the evolving needs of the healthcare market. Jason Cline works closely with the finance department to ensure fiscal agility during periods of rapid expansion. Through the implementation of strategic transformation projects, the Executive Vice President & Transformation Acting Chief Financial Officer strengthens the operational foundation of the company. Cline ensures that financial resources are effectively utilized to support the mission of providing superior renal healthcare management services.

Derek Kung, the Executive Vice President & Chief of Staff at Somatus, coordinates cross-functional initiatives to streamline internal operations. By facilitating communication between departments, the Executive Vice President & Chief of Staff ensures organizational alignment with the mission of supporting patients with Chronic Kidney Disease and End Stage Renal Disease. Kung manages strategic projects that enhance operational efficiency and service delivery across the company. This leadership role involves translating executive directives into actionable workflows that improve patient care outcomes. Derek Kung monitors progress on key performance indicators to maintain high standards of excellence in healthcare management. By optimizing internal processes, the Executive Vice President & Chief of Staff enables the organization to scale effectively while maintaining focus on clinical quality. Through proactive management of organizational priorities, Kung supports the executive team in achieving long-term growth objectives and strengthening the market position of the company within the renal care industry.

Alicia Palmer, the Chief Legal Officer at Somatus, directs all legal, regulatory, and compliance functions for the organization. By navigating the complex landscape of healthcare law, the Chief Legal Officer ensures that all services provided to patients with Chronic Kidney Disease and End Stage Renal Disease adhere to strict industry standards. Palmer manages risk mitigation strategies and oversees contractual agreements with health plans and clinical partners. This leadership role involves providing counsel on regulatory changes that impact the delivery of renal care services. Alicia Palmer protects the intellectual property and corporate interests of the company while fostering a culture of ethical compliance. Through the development of robust legal frameworks, the Chief Legal Officer supports the expansion of operations into new markets. By ensuring full regulatory alignment, Palmer enables the organization to focus on its core mission of improving patient outcomes through specialized healthcare management services.

Bassem Mikhael, the Chief Medical Officer at Somatus, oversees the clinical strategy and quality of care provided to patients with Chronic Kidney Disease and End Stage Renal Disease. By establishing evidence-based clinical protocols, the Chief Medical Officer ensures that the organization delivers superior health outcomes across all service regions. Mikhael directs the medical team in implementing care management programs that reduce hospitalizations and improve patient quality of life. This leadership role involves collaborating with healthcare providers to optimize treatment plans and coordinate care delivery. Bassem Mikhael monitors clinical performance data to identify areas for improvement and innovation in renal care. Through the application of advanced medical expertise, the Chief Medical Officer drives the development of patient-centered solutions that address the unique needs of the renal population. By maintaining high clinical standards, Mikhael supports the company in achieving its goal of transforming the standard of care for patients.